Standard Bariatrics focuses on the development and commercialization of medical devices for bariatric surgery, led by CEO Peter Donato. Its flagship product, the Titan SGS surgical stapler, was cleared by the U.S. FDA on April 28, 2021 and meets the Class II product regulations for surgical staplers. The company works closely with bariatric surgeons to design and release solutions intended to address the global obesity epidemic. Standard Bariatrics plans to use new financing to accelerate commercial efforts for the Titan SGS and related proprietary devices. The business is based in Cincinnati, Ohio and has received multiple rounds of investor support. Standard Bariatrics develops the Titan SGS, a surgical stapler cleared by the FDA in April 2021 for sleeve gastrectomy procedures. The Titan SGS offers real-time audio and visual feedback and a 23-centimeter continuous staple cutline in a single firing. Clinical research cited by the company found faster stapling with fewer leaks and less bleeding versus other staplers. The device began a commercial launch in August supported by an initial tranche of funding, and was used in more than 1,000 procedures with positive physician feedback. Sales surpassed $1 million by November and have since risen to approximately $3 million, and the device was used in the first reported robotic sleeve gastrectomy shortly after launch. The company is using the newly completed financing to continue the commercial rollout and scale adoption. Standard Bariatrics is a Cincinnati-based medical device company and the first commercial spin-out from the Thompson Center at UCRI, founded by Dr. Jonathan Thompson. It has developed an FDA-cleared, reusable device to help surgeons standardize sleeve gastrectomy. The device is currently being used by selected doctors at the University of Cincinnati for a market valuation. The company plans to use its seed funding to generate intellectual property, launch its first products, and prove concepts for future products. Leadership includes Russ Holscher as President and CEO. Financially, Standard Bariatrics closed a seed funding round with Queen City Angels; the amount of the deal was not disclosed.

Total raised

$16M

Funding rounds

3

Latest round

Debt Financing

Latest activity

May 2022